Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodies

US9631025B2 · kind B2 · utility

Assignee

• E.R. SQUIBB & SONS, L.L.C. · US

Inventors

• Cynthia A. Vistica · Dublin, US
• Eric H. Holmes · Tallahassee, US
• Peter Brams · Sacramento, US
• Alison Witte · Scotts Valley, US
• Josephine M. Cardarelli · Redwood City, US

Key dates

• Filing date: Aug 13, 2015
• Grant date: Apr 25, 2017
• Expiry date: Oct 20, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/77
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to Fucosyl-GM1 with high affinity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of this disclosure are also provided. This disclosure also provides methods for detecting Fucosyl-GM1, as well as methods for treating various diseases, including cancer, using anti-Fucosyl-GM1 antibodies.